Stem Memory T Cells (TSCM)-their Role in Cancer and HIV Immunotherapies

Overview

Journal Clin Transl Immunology

Specialty Allergy & Immunology

Date 2014 Dec 16

PMID 25505968

Citations 46

Authors

Jacqueline K Flynn

Paul R Gorry

Affiliations

Soon will be listed here.

Abstract

Stem memory T cells (TSCM) have been described in mice, non-human primates and in humans, constituting approximately 2-4% of the total CD4(+) and CD8(+) T-cell population in the periphery. TSCM represent the earliest and long-lasting developmental stage of memory T cells, displaying stem cell-like properties, and exhibiting a gene profile between naïve and central memory T cells. Their self-renewal capacity and long-term survival has sparked interest in the cancer and human immunodeficiency virus (HIV) fields. How and when the formation of TSCM occurs during the immune response to pathogens and the therapeutic potential of these cells are currently being investigated. This review will explore the potential role of TSCM to be used as, or targeted by, immunotherapies and vaccines for treatment of cancer and HIV.

Citing Articles

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells.

Zhu S, Zuo S, Li C, You X, Jiang E, Feng X J Exp Clin Cancer Res. 2025; 44(1):25.

PMID: 39856752 PMC: 11763111. DOI: 10.1186/s13046-025-03273-2.

Driving CAR-T cells toward solid lung tumors.

Staal F, Avila-Moreno F Mol Ther Oncol. 2024; 32(1):200764.

PMID: 38596284 PMC: 10869736. DOI: 10.1016/j.omton.2024.200764.

Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity.

Huang L, Li H, Zhang C, Chen Q, Liu Z, Zhang J Clin Transl Med. 2024; 14(3):e1620.

PMID: 38468489 PMC: 10928360. DOI: 10.1002/ctm2.1620.

The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments.

Chen T, Deng J, Zhang Y, Liu B, Liu R, Zhu Y Mol Cancer. 2024; 23(1):53.

PMID: 38468291 PMC: 10926606. DOI: 10.1186/s12943-024-01938-8.

New insights into the stemness of adoptively transferred T cells by γc family cytokines.

Luo M, Gong W, Zhang Y, Li H, Ma D, Wu K Cell Commun Signal. 2023; 21(1):347.

PMID: 38049832 PMC: 10694921. DOI: 10.1186/s12964-023-01354-3.

References

Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Fridman W . Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 2014; 3:e28344. PMC: 4063152. DOI: 10.4161/onci.28344. View

Fritsch R, Shen X, Sims G, Hathcock K, Hodes R, Lipsky P . Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol. 2005; 175(10):6489-97. DOI: 10.4049/jimmunol.175.10.6489. View

Haigwood N . Update on animal models for HIV research. Eur J Immunol. 2009; 39(8):1994-9. PMC: 2866064. DOI: 10.1002/eji.200939576. View

Sant A, McMichael A . Revealing the role of CD4(+) T cells in viral immunity. J Exp Med. 2012; 209(8):1391-5. PMC: 3420330. DOI: 10.1084/jem.20121517. View

Baldauf H, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M . SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med. 2012; 18(11):1682-7. PMC: 3828732. DOI: 10.1038/nm.2964. View

Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R . The use of nonhuman primate models in HIV vaccine development. PLoS Med. 2008; 5(8):e173. PMC: 2504486. DOI: 10.1371/journal.pmed.0050173. View

Zhou J, Shen X, Huang J, Hodes R, Rosenberg S, Robbins P . Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol. 2005; 175(10):7046-52. PMC: 1351312. DOI: 10.4049/jimmunol.175.10.7046. View

Gorry P, Ancuta P . Coreceptors and HIV-1 pathogenesis. Curr HIV/AIDS Rep. 2010; 8(1):45-53. DOI: 10.1007/s11904-010-0069-x. View

10.

Geginat J, Sallusto F, Lanzavecchia A . Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med. 2001; 194(12):1711-9. PMC: 2193568. DOI: 10.1084/jem.194.12.1711. View

11.

Finkelstein S, Heimann D, Klebanoff C, Antony P, Gattinoni L, Hinrichs C . Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J Leukoc Biol. 2004; 76(2):333-7. PMC: 1484508. DOI: 10.1189/jlb.0304120. View

12.

Kalia V, Sarkar S, Ahmed R . CD8 T-cell memory differentiation during acute and chronic viral infections. Adv Exp Med Biol. 2010; 684:79-95. DOI: 10.1007/978-1-4419-6451-9_7. View

13.

Klebanoff C, Gattinoni L, Restifo N . CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev. 2006; 211:214-24. PMC: 1501075. DOI: 10.1111/j.0105-2896.2006.00391.x. View

14.

Tilton C, Tabler C, Lucera M, Marek S, Haqqani A, Tilton J . A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets. J Virol Methods. 2013; 195:164-9. PMC: 3982591. DOI: 10.1016/j.jviromet.2013.08.029. View

15.

Walker B, Yu X . Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol. 2013; 13(7):487-98. DOI: 10.1038/nri3478. View

16.

Newell E, Davis M . Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat Biotechnol. 2014; 32(2):149-57. PMC: 4001742. DOI: 10.1038/nbt.2783. View

17.

Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue E, Dragin L . SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012; 13(3):223-228. PMC: 3771401. DOI: 10.1038/ni.2236. View

18.

Luckey C, Weaver C . Stem-cell-like qualities of immune memory; CD4+ T cells join the party. Cell Stem Cell. 2012; 10(2):107-8. PMC: 3277283. DOI: 10.1016/j.stem.2012.01.011. View

19.

Chen K, Huang Y, Chen J . Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin. 2013; 34(6):732-40. PMC: 3674516. DOI: 10.1038/aps.2013.27. View

20.

Tabler C, Lucera M, Haqqani A, McDonald D, Migueles S, Connors M . CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression. J Virol. 2014; 88(9):4976-86. PMC: 3993838. DOI: 10.1128/JVI.00324-14. View